Ligand Pharmaceuticals Total Assets 2006-2019 | LGND

Ligand Pharmaceuticals total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ligand Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $1,261
2017 $671
2016 $602
2015 $503
2014 $258
2013 $105
2012 $104
2011 $121
2010 $76
2009 $142
2008 $171
2007 $173
2006 $326
2005 $315
Ligand Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q3 2019 $1,547
Q2 2019 $1,802
Q1 2019 $1,914
Q4 2018 $1,261
Q3 2018 $2,106
Q2 2018 $1,858
Q1 2018 $755
Q4 2017 $671
Q3 2017 $662
Q2 2017 $640
Q1 2017 $630
Q4 2016 $602
Q3 2016 $601
Q2 2016 $589
Q1 2016 $586
Q4 2015 $503
Q3 2015 $522
Q2 2015 $305
Q1 2015 $263
Q4 2014 $258
Q3 2014 $272
Q2 2014 $100
Q1 2014 $105
Q4 2013 $105
Q3 2013 $102
Q2 2013 $100
Q1 2013 $98
Q4 2012 $104
Q3 2012 $98
Q2 2012 $103
Q1 2012 $110
Q4 2011 $121
Q3 2011 $122
Q2 2011 $127
Q1 2011 $134
Q4 2010 $76
Q3 2010 $113
Q2 2010 $128
Q1 2010 $134
Q4 2009 $142
Q3 2009 $117
Q2 2009 $129
Q1 2009 $140
Q4 2008 $171
Q3 2008 $147
Q2 2008 $160
Q1 2008 $166
Q4 2007 $173
Q3 2007 $212
Q2 2007 $228
Q1 2007 $525
Q4 2006 $326
Q3 2006 $232
Q2 2006 $286
Q1 2006 $289
Q4 2005 $315
Q3 2005 $306
Q2 2005 $302
Q1 2005 $313
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.576B $0.251B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.178B 16.26
CSL (CSLLY) Australia $94.641B 0.00
Gilead Sciences (GILD) United States $79.236B 9.82
Vertex Pharmaceuticals (VRTX) United States $60.170B 61.42
Biogen (BIIB) United States $51.821B 8.89
Illumina (ILMN) United States $48.265B 52.96
Regeneron Pharmaceuticals (REGN) United States $39.933B 17.49
Alexion Pharmaceuticals (ALXN) United States $25.008B 12.35
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.764B 0.00
Seattle Genetics (SGEN) United States $18.624B 0.00
Incyte (INCY) United States $16.941B 39.33
BioMarin Pharmaceutical (BMRN) United States $15.726B 0.00
Genmab (GNMSF) Denmark $13.806B 60.98
Alnylam Pharmaceuticals (ALNY) United States $13.154B 0.00
Galapagos (GLPG) Belgium $13.084B 33.71
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
Exact Sciences (EXAS) United States $11.153B 0.00
BeiGene (BGNE) Cayman Islands $10.362B 0.00
Sarepta Therapeutics (SRPT) United States $9.168B 0.00
Bio-Techne Corp (TECH) United States $8.442B 56.51
BioNTech SE (BNTX) Germany $8.268B 0.00
QIAGEN (QGEN) Netherlands $8.042B 26.22
Guardant Health (GH) United States $7.861B 0.00
Amarin (AMRN) Ireland $7.527B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.164B 18.21
Moderna (MRNA) United States $6.978B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.680B 0.00
Reata Pharmaceuticals (RETA) United States $6.446B 0.00
Exelixis (EXEL) United States $6.004B 16.89
Ascendis Pharma (ASND) Denmark $5.895B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.844B 0.00
Bluebird Bio (BLUE) United States $5.302B 0.00
Repligen (RGEN) United States $5.258B 95.29
China Biologic Products (CBPO) China $4.581B 25.81
MorphoSys AG (MOR) Germany $4.187B 0.00
Blueprint Medicines (BPMC) United States $3.923B 0.00
Mirati Therapeutics (MRTX) United States $3.669B 0.00
Immunomedics (IMMU) United States $3.631B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.410B 0.00
NeoGenomics (NEO) United States $3.381B 179.89
MyoKardia (MYOK) United States $3.363B 0.00
Adaptive Biotechnologies (ADPT) United States $3.332B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.298B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.208B 0.00
Zai Lab (ZLAB) China $3.030B 0.00
Emergent Biosolutions (EBS) United States $2.959B 29.40
Alkermes (ALKS) Ireland $2.918B 0.00
Genmab (GMAB) Denmark $2.907B 5.99
Halozyme Therapeutics (HALO) United States $2.873B 0.00
Acceleron Pharma (XLRN) United States $2.871B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.859B 0.00
UniQure (QURE) Netherlands $2.712B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Epizyme (EPZM) United States $2.369B 0.00
Arena Pharmaceuticals (ARNA) United States $2.276B 5.29
RA PHARMCTL INC (RARX) United States $2.209B 0.00
Denali Therapeutics (DNLI) United States $2.114B 0.00
Myriad Genetics (MYGN) United States $2.113B 31.22
Principia Biopharma (PRNB) United States $1.977B 0.00
Zymeworks (ZYME) Canada $1.880B 0.00
Insmed (INSM) United States $1.866B 0.00
Fate Therapeutics (FATE) United States $1.844B 0.00
Arvinas (ARVN) United States $1.714B 0.00
REGENXBIO (RGNX) United States $1.703B 0.00
Akcea Therapeutics (AKCA) United States $1.628B 0.00
Editas Medicine (EDIT) United States $1.535B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.532B 0.00
Alector (ALEC) United States $1.516B 0.00
Intra-Cellular Therapies (ITCI) United States $1.409B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.377B 0.00
Coherus BioSciences (CHRS) United States $1.352B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.203B 0.00
Zealand Pharma (ZEAL) Denmark $1.168B 0.00
DBV Technologies S.A (DBVT) France $1.136B 0.00
Codexis (CDXS) United States $1.029B 0.00
Revance Therapeutics (RVNC) United States $0.997B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Sangamo Therapeutics (SGMO) United States $0.958B 0.00
Mesoblast (MESO) Australia $0.953B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
Heska (HSKA) United States $0.827B 211.32
ZIOPHARM Oncology Inc (ZIOP) United States $0.807B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.800B 6.72
GENFIT S.A (GNFT) France $0.776B 0.00
Cellectis S.A (CLLS) France $0.765B 0.00
Vericel (VCEL) United States $0.749B 279.42
Adverum Biotechnologies (ADVM) United States $0.747B 0.00
Twist Bioscience (TWST) United States $0.736B 0.00
ANI Pharmaceuticals (ANIP) United States $0.735B 12.54
Cytokineticsorporated (CYTK) United States $0.717B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Sorrento Therapeutics (SRNE) United States $0.705B 0.00
Intellia Therapeutics (NTLA) United States $0.702B 0.00
UROGEN PHARMA (URGN) United States $0.693B 0.00
Retrophin (RTRX) United States $0.688B 0.00
Cara Therapeutics (CARA) United States $0.675B 0.00
Anika Therapeutics (ANIK) United States $0.655B 21.25
AC Immune SA (ACIU) Switzerland $0.638B 14.77
NantKwest (NK) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.594B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.544B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.540B 0.00
Precision BioSciences (DTIL) United States $0.540B 0.00
Agenus (AGEN) United States $0.536B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.515B 0.00
BioDelivery Sciences (BDSI) United States $0.515B 0.00
Clovis Oncology (CLVS) United States $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.511B 0.00
Bellus Health (BLU) Canada $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.460B 0.00
Cel-Sci (CVM) United States $0.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.433B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.433B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.430B 2.98
AnaptysBio (ANAB) United States $0.422B 0.00
Merus (MRUS) Netherlands $0.399B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.390B 0.00
Gritstone Oncology (GRTS) United States $0.386B 0.00
Mersana Therapeutics (MRSN) United States $0.384B 0.00
Kindred Biosciences (KIN) United States $0.383B 0.00
Puma Biotechnology (PBYI) United States $0.381B 0.00
Avid Bioservices (CDMO) United States $0.366B 0.00
PDL BioPharma (PDLI) United States $0.365B 9.14
Inovio Pharmaceuticals (INO) United States $0.356B 0.00
MannKind (MNKD) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Pfenex (PFNX) United States $0.347B 0.00
Stemline Therapeutics (STML) United States $0.347B 0.00
Cue Biopharma (CUE) United States $0.345B 0.00
CytomX Therapeutics (CTMX) United States $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
OSMOTICA PHARM (OSMT) United States $0.335B 0.00
Syros Pharmaceuticals (SYRS) United States $0.332B 0.00
Compugen (CGEN) Israel $0.327B 0.00
Novavax (NVAX) United States $0.315B 0.00
Albireo Pharma (ALBO) United States $0.313B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
VBI Vaccines (VBIV) United States $0.296B 0.00
Geron (GERN) United States $0.282B 0.00
Sutro Biopharma (STRO) United States $0.280B 0.00
IVERIC Bio (ISEE) United States $0.280B 0.00
Kamada (KMDA) Israel $0.276B 8.06
WAVE Life Sciences (WVE) Singapore $0.275B 0.00
ADMA Biologics Inc (ADMA) United States $0.263B 0.00
Prometic Life Sciences (LMNL) Canada $0.261B 0.00
ChromaDex (CDXC) United States $0.260B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Exicure (XCUR) United States $0.221B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
Cerecor (CERC) United States $0.217B 0.00
XOMA (XOMA) United States $0.217B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.210B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Athersys (ATHX) United States $0.201B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Fortress Biotech (FBIO) United States $0.191B 0.00
Windtree Therapeutics (WINT) United States $0.183B 0.00
CorMedix Inc (CRMD) United States $0.182B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.177B 0.00
ARAVIVE, INC (ARAV) United States $0.176B 0.00
Alcobra (ARCT) United States $0.175B 0.00
Spero Therapeutics (SPRO) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Selecta Biosciences (SELB) United States $0.168B 0.00
TELA Bio (TELA) United States $0.166B 0.00
PHASEBIO PHARMA (PHAS) United States $0.162B 0.00
Palatin Technologies (PTN) United States $0.162B 4.41
Dyadic (DYAI) United States $0.161B 0.00
Menlo Therapeutics (MNLO) United States $0.157B 0.00
Aptinyx (APTX) United States $0.156B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
Strongbridge Biopharma (SBBP) United States $0.147B 3.94
Abeona Therapeutics (ABEO) United States $0.142B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Verastem (VSTM) United States $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.133B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.127B 6.55
Clearside Biomedical (CLSD) United States $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.125B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Arsanis (XFOR) United States $0.124B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.121B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Aduro Biotech (ADRO) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.112B 0.00
Antibe Therapeutics (ATBPF) Canada $0.111B 0.00
OvaScience (MLND) United States $0.106B 0.00
Synlogic (SYBX) United States $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.099B 0.00
Proteostasis Therapeutics (PTI) United States $0.098B 0.00
Acorda Therapeutics (ACOR) United States $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.096B 0.00
Catalyst Biosciences (CBIO) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
NewLink Genetics (NLNK) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.082B 5.30
Trevena (TRVN) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.074B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Organovo Holdings (ONVO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Soligenix (SNGX) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Celsion (CLSN) United States $0.038B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Unum Therapeutics (UMRX) United States $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
AmpliPhi Biosciences (ARMP) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.018B 0.00
Advaxis (ADXS) United States $0.018B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
BioPharmX (BPMX) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.005B 0.00